bioRxiv Science⌕ Search

Biology subjects

Bardhan, A.

Publications and source records attributed to Bardhan, A..

5 recordsLinked to original sources

Lupeol, a bioactive compound of tamarind, functions as a potent inhibitor of hepatitis C virus (HCV) entry through disruption of the E2-CD81 interaction.

Hepatitis C virus (HCV) infection remains a major global health challenge despite the success of direct-acting antivirals (DAAs), which are limited by high cost, restricted accessibility, and the emergence of resistant strains. Natural products, particularly phytochemicals, represent a promising reservoir of antiviral agents with diverse mechanisms of action and favorable safety profiles. In this study, we combined wet-lab experimentation with computational approaches to identify plant-derived molecules capable of inhibiting HCV entry. Guided by ethnobotanical evidence, methanolic leaf extracts of Psidium guajava L., Plumeria alba L., Syzygium cumini L., and Tamarindus indica L. were prepared and evaluated for cytotoxicity in Huh7 hepatoma cells. Entry inhibition was assessed using EGFP-labelled HCV pseudoparticles (HCVpp) by qRT-PCR and confocal microscopy. Among the tested plants, Tamarindus indica extract significantly reduced KGFP expression (p < 0.05), confirmed by {Delta}{Delta}Cq analysis and impaired membrane fusion events, while Psidium guajava and Plumeria alba impaired intracellular trafficking without blocking initial attachment. Syzygium cumini showed no inhibitory effect under the tested conditions. Complementary in silico analyses included homology modelling, molecular docking, ADME/toxicity profiling, and molecular dynamics simulations of HCV E2-ligand complexes. Literature mining identified 39 candidate compounds, among which lupeol exhibited stable binding interactions with HCV E2 and favorable pharmacokinetic properties. Critically, in vitro binding assays confirmed that lupeol disrupted the E2-CD81 interaction, reducing bound E2-EGFP to 6% compared to controls. This was supported by HCV-pseudoparticle entry assays confirming inhibition of entry. Together, these findings establish Tamarindus indica and lupeol as potent HCV entry inhibitors.

microbiology↗

High-throughput discovery of arginine-depleted peptides enables effective antisense delivery for Duchenne muscular dystrophy

Phosphorodiamidate morpholino oligomers (PMOs) are approved exon-skipping antisense therapeutics for Duchenne muscular dystrophy (DMD), but their clinical utility is limited by poor uptake in muscle tissue, necessitating frequent high-dose administration. Cell-penetrating peptides (CPPs) can enhance intracellular delivery of PMOs, yet conventional arginine-rich CPPs often cause dose-limiting toxicity, including renal damage, which hinders their clinical translation. To address this challenge, we developed a high-throughput, charge-based chromatographic enrichment platform capable of screening over 15,000 synthetic peptides, including sequences with noncanonical (abiotic) amino acids. This approach enabled de novo discovery of arginine-depleted CPPs with improved delivery profiles. Four lead candidates demonstrated efficient nuclear PMO delivery with ~10-fold lower in vitro toxicity compared to standard CPPs such as penetratin. The top-performing peptide, CXP1, showed robust splice-switching activity and favorable tolerability in both cellular and animal models. In dystrophic mdx mice, CXP1-PMO conjugates achieved greater exon skipping compared to PMOs conjugated to R6G at equivalent doses. Tissue levels of CXP1-PMO correlated with exon-skipping efficacy, establishing a clear pharmacokinetic-pharmacodynamic relationship. These findings highlight a mechanistically novel and translationally relevant discovery strategy, demonstrating the potential of high-throughput platforms to generate more effective CPP-based delivery vehicles for antisense therapeutics in DMD and related neuromuscular disorders. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=44 SRC="FIGDIR/small/730741v1_ufig1.gif" ALT="Figure 1"> View larger version (13K): org.highwire.dtl.DTLVardef@84b7f2org.highwire.dtl.DTLVardef@1487850org.highwire.dtl.DTLVardef@d2e263org.highwire.dtl.DTLVardef@10ce371_HPS_FORMAT_FIGEXP M_FIG C_FIG

bioengineering↗

Sex without crossing over in the yeast Saccharomycodes ludwigii

Meiotic recombination is a ubiquitous function of sexual reproduction throughout eukaryotes. Here we report that recombination is extremely suppressed during meiosis in the yeast species Saccharomycodes ludwigii. DNA double-strand break formation, processing and repair are required for normal meiosis but do not lead to crossing over. Although the species has retained an intact meiotic gene repertoire, genetic and population analyses suggest the exceptionally rare occurrence of meiotic crossovers. We propose that Sd. ludwigii has followed a unique evolutionary trajectory that possibly derives fitness benefits from the combination of frequent fertilization within the meiotic tetrad with the absence of meiotic recombination.

genetics↗

Photochemical NOT Gate for DNA Computing

DNA-based Boolean logic gates (AND, OR and NOT) can be assembled into complex computational circuits that generate an output signal in response to specific patterns of oligonucleotide inputs. However, the fundamental nature of NOT gates, which convert the absence of an input into an output, makes their implementation within DNA-based circuits difficult. Premature execution of a NOT gate before completion of its upstream computation introduces an irreversible error into the circuit. We developed a novel DNA gate design utilizing photocaging groups that prevents gate function until irradiation at a certain time-point. Optical activation provides temporal control over circuit performance by preventing premature computation and is orthogonal to all components of DNA computation devices. Using this approach, we designed NAND and NOR logic gates that respond to synthetic microRNA inputs. We further demonstrate the utility of the NOT gate within multi-layer circuits in response to a specific pattern of four microRNAs.

synthetic biology↗

Spatiotemporal Control of CRISPR/Cas9 Function in Cells and Zebrafish using Light-Activated Guide RNA

We developed a new method for conditional regulation of CRISPR/Cas9 activity in mammalian cells and zebrafish embryos via photochemically activated, caged guide RNAs. Caged gRNAs are generated by substituting four nucleobases evenly distributed throughout the 5-protospacer region with caged nucleobases during synthesis. Caging confers complete suppression of gRNA:target dsDNA hybridization and rapid restoration of CRISPR/Cas9 function upon optical activation. This tool offers simplicity and complete programmability in design, high spatiotemporal specificity in cells and zebrafish embryos, excellent off to on switching, and stability by preserving the ability to form Cas9:gRNA ribonucleoprotein complexes. caged gRNAs are novel tools for conditional control of gene editing thereby enabling the investigation of spatiotemporally complex physiological events by obtaining a better understanding of dynamic gene regulation.

developmental biology↗